Education
About Us
Working with TipRanks
Follow Us
Bioxyne Limited (AU:BXN)
ASX:BXN
BXN Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.06
Previous CloseN/A
Volume631.90K
Average Volume (3M)5.48M
Market Cap
AU$115.11M
Enterprise ValueAU$55.33M
Total Cash (Recent Filing)AU$2.68M
Total Debt (Recent Filing)AU$1.73M
Price to Earnings (P/E)48.2
Beta0.60
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding2,171,828,600
10 Day Avg. Volume4,810,356
30 Day Avg. Volume5,475,012
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Bioxyne Limited News
BXN FAQ
What was Bioxyne Limited’s price range in the past 12 months?
Bioxyne Limited lowest share price was <AU$0.01 and its highest was AU$0.06 in the past 12 months.
What is Bioxyne Limited’s market cap?
Bioxyne Limited’s market cap is AU$115.11M.
When is Bioxyne Limited’s upcoming earnings report date?
Bioxyne Limited’s upcoming earnings report date is Aug 27, 2025 which is in 5 days.
How were Bioxyne Limited’s earnings last quarter?
Bioxyne Limited released its earnings results on Feb 27, 2025. The company reported AU$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.002.
Is Bioxyne Limited overvalued?
According to Wall Street analysts Bioxyne Limited’s price is currently Overvalued.
Does Bioxyne Limited pay dividends?
Bioxyne Limited does not currently pay dividends.
What is Bioxyne Limited’s EPS estimate?
Bioxyne Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioxyne Limited have?
Bioxyne Limited has 2,171,828,600 shares outstanding.
What happened to Bioxyne Limited’s price movement after its last earnings report?
Bioxyne Limited reported an EPS of AU$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bioxyne Limited?
Currently, no hedge funds are holding shares in AU:BXN
Bioxyne Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:BXN Sentiment 86%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth AU$43.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
150.00%
12-Months-Change
Fundamentals
Return on Equity
55.63%
Trailing 12-Months
Asset Growth
215.17%
Trailing 12-Months
Company Description
Bioxyne Limited
Bioxyne Limited (BXN) is an Australian life sciences and health products company focused on the development, manufacturing, and distribution of consumer health products. The company primarily operates in the health and wellness sector, offering a range of probiotic and functional food products aimed at improving health and well-being. Bioxyne leverages its expertise in biotechnology to deliver products that support immune health, gut health, and general wellness.
Technical Analysis
Wellnex Life Ltd
―
EVE Health Group Limited
―
Holista Colltech Limited
―
Clover Corporation Limited
―
Maggie Beer Holdings Ltd.
―
Ownership Overview
1.26% Insiders
―
Mutual Funds
― Other Institutional Investors
98.74% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---